$HCWB

HCW Biologics CFO Rebecca Byam bought 14,235 shares of NASDAQ:HCWB on May 22 at an average $1.41/share, for about $20,071, according to an SEC filing. The purchase raised her direct stake to 57,245 shares (~$80,715). The stock fell 26% recently to $1.94. The company reported $0.37 EPS and $6.54M revenue for the quarter.